logo
banner
banner

Shaping the future of science, together

We designed the first edition of the THRPTX Innovation Summit as a catalyst for scientific excellence, a place where experts, decisionmakers and informed observers could come together to share their visions of tomorrow’s health.
By facilitating a space for pioneering dialogue on science, the Servier Group is proud to spotlight therapeutic innovations that will positively impact the health care ecosystem. Because these innovations open up new perspectives for patients.

Olivier Laureau

President of Servier

author

An international scientific summit to collectively reflect on major therapeutic advances in oncology

THRPTX PROGRAM

June 18TH, 2024 - FROM 2:00 PM TO 6:00 PM - AT SERVIER PARIS-SACLAY R&D INSTITUTE

Participant registration starts at 1:30 PM.

INTRODUCTION

BY OLIVIER LAUREAU, PRESIDENT OF SERVIER.

OPENING KEYNOTE

BY PROFESSOR WILLIAM G. KAELIN JR, 2019 NOBEL LAUREATE IN PHYSIOLOGY AND MEDICINE.

FIRST SESSION

Discussion with leading international experts in oncology on therapeutic innovation and its solutions for cancer patients:

  • Hsin-An Hou, Hematologist at National Taiwan University Hospital
  • Susan Pandya, Vice President Clinical Development, Global Head of Cancer Metabolism at Servier
  • Hans Scheurer, PhD, CEO at Myeloma Patients Europe and Vice-chair at European Cancer Patient Advocacy Networks
  • Ines Vaz-Luis, MD, Medical oncologist at Gustave Roussy and instructor in Medicine at Harvard University
  • Andrew Wei, MBBS, PhD, co-leads the acute myeloid leukemia program at the Peter MacCallum Cancer Center and Royal Melbourne Hospital in Melbourne, Australia

COFFEE BREAK

SECOND SESSION

Discussion with high-profile speakers on how society copes with breakthrough therapeutic innovation

  • Sandrine Bourguignon, Professor of Health Economy at Paris Dauphine-PSL & RWEality co-founder & CEO
  • David Edwards, PhD, Harvard University, Associate in Bioengineering and founder of the World Frontiers Forum think tank
  • Dipak Kalra, MB BS, President of the European Institute for Innovation Through Health Data
  • Hugues de Thé, MD, PhD, Professor at the Collège de France, holder of the Chair in Cellular and Molecular Oncology, member of the Academy of Science

Panels moderated by Ariane Warlin

FIRESIDE CHAT

A WRAP-UP DISCUSSION between Professor William G. Kaelin Jr and Selena Bouffette, PhD Student Paris Saclay University and member of the Servier post-doctoral community.

CONCLUSION

BY DR. CLAUDE BERTRAND, EVP RESEARCH AND DEVELOPMENT AT SERVIER.

Possibility to visit the research facilities and to network with guests and speakers.

Add to calendar Download leaflet

Panel of leading international scientific experts

The half-day event will feature leading international scientific experts, under the patronage of Professor William G. Kaelin Jr, Professor of Medicine at Harvard University and recipient of the 2019 Nobel Prize in Medicine.

Professor William G. Kaelin JR

2019 Nobel laureate in physiology and medicine

FIRST PANEL DISCUSSION

Science and medical innovation to support cancer patients

Hsin-An Hou

Hematologist at National Taiwan University Hospital

linkedin profile

Susan Pandya

Vice President Clinical Development, Global Head of Cancer Metabolism 
at Servier

linkedin profile

Hans Scheurer

VPhD, CEO at Myeloma Patients Europe and Vice-chair at European Cancer Patient Advocacy Networks

linkedin profile

Ines Vaz-Luis

Medical oncologist at Gustave Roussy, instructor in Medicine at Harvard

linkedin profile

Andrew Wei

PhD, co-leads the acute myeloid leukemia program at the Peter MacCallum Cancer Centre and Royal Melbourne

linkedin profile

SECOND PANEL DISCUSSION

The impact of health innovation on society

Sandrine Bourguignon

Professor of Health Economy at Paris Dauphine-PSL & RWEality co-founder & CEO

linkedin profile

David Edwards

PhD, Harvard University, Associate in Bioengineering and founder of the World Frontiers Forum think tank

linkedin profile

Dipak Kalra

MB BS, President of the European Institute for Innovation Through Health Data

linkedin profile

Hugues de Thé

MD, PhD, Professor at the Collège de France, holder of the Chair in Cellular and Molecular Oncology

linkedin profile

Contact us

If you have any question regarding the THRPTX event, please do not hesitate to contact the team at thrptx@servier.com

As the data controller, Servier International, located 50 rue Carnot 92284 Suresnes, France, collects and processes your personal data for compliance purposes (especially transparency), based on its legitimate interests which are to comply with any guidelines applicable to pharmaceutical industries; or based on legal and regulatory obligations, depending on the country. Your personal data will be communicated to the employees of Servier International and of any affiliates of the Servier Group, on a need to know basis to fulfil the purpose; and to competent authorities in certain legally defined cases. The data processors of Servier International may also process your personal data as strictly required for the performance of their task. In the case Servier International transfers your personal data in a country located outside the European Union and not recognized by the European Commission as providing an adequate level of protection for personal data, Servier International undertakes to secure the transfer in compliance with the applicable data privacy regulations. Your personal data will be kept for no longer than is necessary to fulfil the permitted purpose.
You have a right of access, rectification and erasure of your personal data, a right to the restriction of the processing and a right to object to the processing. To exercise your rights, you may send an email to the data protection contact of Servier International at the following address: dataprivacy@servier.com. If Servier International does not answer to your request, you may lodge a complaint before the CNIL, the French supervisory authority.